beta

You're viewing our new website - find out more

Publication - Consultation Paper

Clinical Trial Access quality performance indicator: consultation

Published: 3 Jul 2017
Part of:
Health and social care
ISBN:
9781788510912

Consultation on the effectiveness of the Clinical Trial Access quality performance indicator (QPI) as part of the National Cancer QPIs.

20 page PDF

492.4kB

20 page PDF

492.4kB

Contents
Clinical Trial Access quality performance indicator: consultation
Appendix 4 - Definition of eligibility for addition to the UKCRN Portfolio

20 page PDF

492.4kB

Appendix 4 - Definition of eligibility for addition to the UKCRN Portfolio

Research taking place in NHSScotland can be added to the UKCRN Portfolio if it falls into one of the following categories:

(a) Studies supported by a funder which appears on the CSO Eligible Funders list can be added automatically.

http://www.cso.scot.nhs.uk/wp-content/uploads/2013/05/NRS-Funding-Guidance-Annex-2-Eligible-funders-v4.pdf

(b) Studies which are supported by a funder which is not on the list may apply for adoption to the Portfolio if funding is provided by:

  • an overseas government or
  • an ineligible national charity or
  • a commercial concern, but are non-commercially sponsored

The process varies depending on lead site and participating sites:

  • Studies led from England with Scottish sites can be considered for adoption by the NIHR CRN
  • Scottish-led studies which intend to also recruit in England can be considered for adoption via the NIHR CRN process
  • Studies only taking place in Scotland can apply for adoption through the defined process (link below)

http://www.cso.scot.nhs.uk/wp-content/uploads/2013/05/NRS-Funding-Guidance-Annex-3-SOP-for-Adoption-v2.1.pdf

(c) All industry-led studies (where the study has been initiated, funded and sponsored by the company) are eligible for addition to the Scottish Portfolio. Where a study is led from England, this may be carried out by NIHR, however due to concerns over confidentiality, not all industry-led studies active in Scotland will be added to the Portfolio. Activity on all Scottish-led studies is tracked by NRS Commercial Managers.

If a study does not fall into any of the above categories, it should not be added to the UKCRN Portfolio.

Addition of Scottish studies to the UKCRN Portfolio

NHS Boards are responsible for addition of eligible research projects led from Scotland to the UKCRN Portfolio.

The primary contact for addition should be the R&D office of the NHS Board which hosts the study Chief Investigator.

Boards may delegate the actual addition and maintenance of the Portfolio entry to another party, such as a Research Network, but are ultimately responsible if the study has not been added or maintained.

Further information on Scottish Studies and the UKCRN Portfolio can be found at:

http://www.cso.scot.nhs.uk/wp-content/uploads/Scottish-studies-and-the-UKCRN-Portfolio.pdf


Contact

Email: Chris Booth, chris.booth@gov.scot

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road
Edinburgh
EH1 3DG